Evidence map›Paper›PMID 42872145›Full record

ArticleJournal of medical cases2026

Adult Thalamic Diffuse Midline Glioma, H3 K27-Altered, With

Muralidhar Idamakanti, Rani Indrani Bijjam, Yasvin Onkarappa Mangala

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical cases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muralidhar IdamakantiAdult Inpatient Medical Services (AIMS), Presbyterian Healthcare Services (PHS), Albuquerque, NM 87106, USA.ORCID https://orcid.org/0009-0004-3599-3003
Rani Indrani BijjamAdult Inpatient Medical Services (AIMS), Presbyterian Healthcare Services (PHS), Albuquerque, NM 87106, USA.ORCID https://orcid.org/0000-0001-6493-0272
Yasvin Onkarappa MangalaDepartment of Hematology/Oncology, Presbyterian Healthcare Services (PHS), Albuquerque, NM 87106, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffuse midline glioma (DMG) is a highly aggressive central nervous system neoplasm that predominantly affects pediatric populations and is associated with a dismal prognosis. Adult DMGs remain relatively uncommon and continue to pose significant diagnostic and therapeutic challenges. We present the case of a 54-year-old adult patient with a left thalamic DMG, H3 K27-altered, World Health Organization (WHO) grade 4, harboring pathogenic

Indexed as

Adult diffuse midline gliomaDordaviproneEarly CSF disseminationH3F3A K27M and KRAS G12V comutationMAPK pathwayRadiotherapy

Identifiers

PMID42872145
PMCPMC13661092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.